STEPHEN CULLEN: Open Payments
NPI 1679838387 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 29 payments from 6 companies in 2025. Trend: 2023 $1,096 · 2024 $1,152 · 2025 $773
Food & beverage: $673Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $472 |
| ABBVIE INC. | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $70 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23 |
| Amgen Inc. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, Rhapsido, DUPIXENT, Cabtreo, RINVOQ, COSENTYX, OTEZLA.
Industry payments across RI — which companies pay providers there.
